Orders are usually processed within 1–2 working days and shipped Monday–Friday.

Login
Retatrutide 60mg Vial

Retatrutide 60mg Vial

£150

Out of Stock

Product Specifications

Out of stock

Retatrutide is an investigational triple receptor agonist peptide targeting GLP-1, GIP, and glucagon receptors.
It is currently being studied for its potential impact on metabolic regulation and body weight management in research settings.
Key Research Characteristics
  • Triple agonist activity: GLP-1 / GIP / Glucagon receptors
  • Designed to influence both energy intake and energy expenditure
  • Long-acting peptide under clinical development
Mechanism Overview
Retatrutide combines incretin receptor activation (GLP-1 and GIP) with glucagon receptor stimulation.
This multimodal approach is being investigated for its potential to:
  • Support glucose-dependent insulin signaling
  • Modulate appetite pathways
  • Increase metabolic rate and lipolysis
  • Influence cardiometabolic biomarkers
Research Applications
  • Obesity and metabolic disorder research
  • Glucose metabolism studies
  • Energy balance and fat metabolism investigations
  • Hepatic fat and cardiometabolic marker evaluation
For research use only. Not for human consumption.
​

 

Reviews

No reviews yet.

Add a review

Related Research Products

Browse similar research peptides available for controlled laboratory applications.

Tirzepatide 30mg Vial

£65
Best Seller

Tirzepatide 60mg Vial

£110

Retatrutide 10mg Vial

£60

Retatrutide 30mg Vial

£100

Semaglutide 10mg Vial

£35

Tirzepatide 120mg Vial

£175

Mazdutide 10mg Vial

£45

Related Research Products

Browse similar research peptides available for controlled laboratory applications.

Purity Tested

Each batch is prepared with strict quality control.

Fast EU delivery

Orders processed within 1–2 business days.

Expert Support

Unlimited after-sale advice

Research Grade

Secure and easy payment options


Select your currency
GBP Pound sterling
EUR Euro